75 (18-45 years) caesarean section were done in RMCH from 2015 July to 2015 December, who received Hyperbaric 0.5% Bupivacain 2.5 ml at the site of L 2-3, L3-4 and L 4-5 inter vertebral spaces. All patients used 25 gauze spinal Needles after 5 & 10 minutes analgesia effect at the level of T10 and T6 respectively. But analgesia effect at the level of T4 was found 15-20 minutes. SPO2 were not significantly different among the three groups, but small changes of HR and BP among them.TAJ 2015; 28(1): 1-5
Background: Recurrent posterior epistaxis is a challenging problem for most otolaryngologists. Of the several proposed treatment modalities, endoscopic ligation of SPA (Sphenopalatine artery) provides a simple and effective solution with relatively minor complications. Objectives: Aim of this study was to find out the success rate and complications of endoscopic ligation of SPA in the management of recurrent posterior epistaxis. Materials and Methods: This was an observational study conducted from Jan 2019 to Jan 2021. Total 60 patients were included in this study. Inclusion criteria were - recurrent epistaxis (at least 4 episodes in last 2 months) with bleeding point not seen in anterior rhinoscopy, Failure of previous conservative management with medications and nasal packing, age between 18–60 years of both sexes. All the patients underwent trans-nasal endoscopic Sphenopalatine artery ligation, and patients were followed up for 12 weeks to identify repeated bleeding and to evaluate complications. Results: In this study male to female ratio was 1.5:1. Mean age of study group was 44.66 (±8.62) years. No recurrent bleeding occurred in 51 (85%) and in 9 (15%) nasal bleeding occurred in the 2 months postoperative period. Anesthesia of incisor teeth occurred in 18 patients (30%), 22 patients (37%) complained about increased nasal crusting. Conclusion: Endoscopic ligation of Sphenopalatine artery shows good outcome in prevention of further episodes of epistaxis in most patients. Although some minor complications can occur, these are manageable. KYAMC Journal. 2021;12(3): 133-137
Background: Globus pharyngeus or feeling of a lump in the throat is a very common complaint in patients visiting the otolaryngology outpatient department. Pharmacotherapy with low dose amitriptyline has a significant effect in relieving the symptoms, although success rate varies among patients. Objectives: Aim for this study was to find out the benefits of low dose amitriptyline therapy in the management of Globus pharyngeus on a short term basis. Materials & Methods: This is an observational study conducted from Jan 2019 to Jan 2020. Total 50 patients were included in this study. Inclusion criteria were – subjective feeling of a lump in the throat persisting for more than 2 months, Clinical oral examination and Upper GI endoscopy revealed normal findings, age between 18–60 years of both sexes. All the patients were prescribed with 10mg Amitriptyline per oral at night for 2 months, and patients were followed during the course of treatment to assess relief of symptoms and to evaluate any side effects. Results: In this study male to female ratio was 1:4. Mean age of study group was 42.66 (_ 4.78) years. Symptomatic relief occurred in 37 (74%) patients. Increased somnolence was found in 21 patients (42%) during first 2 weeks of treatment, No improvement occurred in 8 patients (16%), and worsening of symptom occurred in 5 patients (10%). Conclusion: Low dose Amitriptyline is effective in alleviating symptoms of globus pharyngeus in most patients on a short-term basis. Although some minor side effects can occur, these are manageable. KYAMC Journal.2021;12(02): 75-77
In Rajshahi Medical College Hospital this experience was based on 8 patients who got high spinal block for intended surgery for Caesarian section. These patients were totally apnoeic, cyanosed and there was no recordable pulse or blood pressure. Cardiac massage and artificial ventilation with rapidly introduced E.T.T. were instituted and inotrope Ephedrine was given without recovery. But when adrenaline was given in diluted form, soon pulse, B.P. respiration and consciousness were regained.
Objective: In this study, the two methods of myringoplasty (underlay and over-underlay technique) were compared. Methods: Total 100 patients of COM (inactive mucosal variety) were studied for 06 months duration from 1st Oct 2015 to 31st March 2016 in the Dept of ENT & Head Neck Surgery, CMH Dhaka. The diagnosed cases of COM patients were selected according to the eligibility criteria’s by purposive sampling. 100 patients were equally divided into two groups. Patients in group1 underwent underlay method and patients in group 2 underwent over-underlay technique of myringoplasty. Patients were followed up for 6 months. Results: Graft uptake and hearing improvement was compared in both groups. In group 1 (underlay myringoplasty) graft taken rate was 92% and graft failure rate was 8%. In group 2 (Over-underlay myringoplasty) graft taken rate was 94% and failure rate was 6%. Graft uptake was 2% lower in the group1 than group 2 .The gain in hearing threshold (gain in A-B gap) in the group 1 (underlay myringoplasty) was (23.74 dB ± 3.97) and in group 2 )over-underlay myringoplasty) was (23.64 dB ± 4.03) Conclusion: The present study emphasizes the fact that there is no significant difference in short term results between the two techniques (underlay and over-underlay). Bangladesh J Otorhinolaryngol; October 2017; 23(2): 133-139
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.